Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No
- 29 February 2008
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 86 (2) , 148-153
- https://doi.org/10.1016/j.radonc.2007.12.024
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancerRadiotherapy and Oncology, 2007
- Proton beam therapy – Do we need the randomised trials and can we do them?Radiotherapy and Oncology, 2007
- Proton therapy – A systematic review of clinical effectivenessRadiotherapy and Oncology, 2007
- Proton Therapy in Clinical Practice: Current Clinical EvidenceJournal of Clinical Oncology, 2007
- Neutron scattered dose equivalent to a fetus from proton radiotherapy of the motherMedical Physics, 2006
- The Weight of Evidence Does Not Support the Suggestion that Exposure to Low Doses of X Rays Increases LongevityRadiology, 2003
- Tumorigenesis in High-Dose Total Body Irradiated Rhesus Monkeys--A Life Span StudyToxicologic Pathology, 2003
- The Relative Costs of Proton and X-ray Radiation TherapyClinical Oncology, 2003
- Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patientsPublished by Elsevier ,2000
- A Randomized Controlled Trial of Varying Radiation Doses in the Treatment of Choroidal MelanomaArchives of Ophthalmology (1950), 2000